Fernando Aguirre Synchrony Financial (SYF) insider trading activity

Fernando Aguirre is Director of Synchrony Financial. Currently has a direct ownership of 26,272 shares of SYF, which is worth approximately $1.53 Million. The most recent transaction as insider was on Mar 31, 2022, when has been sold 1,186 shares (Common Stock) at a price of $34.81 per share, resulting in proceeds of $41,285. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.3K

4.19% 3M change

15.09% 12M change

Total Value Held $1.53 Million

FERNANDO AGUIRRE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2022	BUY Grant, award, or other acquisition	$41,285 $34.81 p/Share	1,186 Added 8.81%	12,282 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	$742 $43.66 p/Share	17 Added 0.15%	11,096 Dividend Equivalent Unit
Dec 31 2021	BUY Grant, award, or other acquisition	$41,287 $46.39 p/Share	890 Added 7.44%	11,079 Common Stock
Nov 12 2021	BUY Grant, award, or other acquisition	$753 $50.18 p/Share	15 Added 0.15%	10,189 Dividend Equivalent Unit
Sep 30 2021	BUY Grant, award, or other acquisition	$41,255 $48.88 p/Share	844 Added 7.66%	10,174 Common Stock
Aug 12 2021	BUY Grant, award, or other acquisition	$826 $51.62 p/Share	16 Added 0.17%	9,330 Dividend Equivalent Unit
Jun 30 2021	BUY Grant, award, or other acquisition	$33,770 $48.52 p/Share	696 Added 6.95%	9,314 Common Stock
May 13 2021	BUY Grant, award, or other acquisition	$1,041 $45.27 p/Share	23 Added 0.27%	8,618 Dividend Equivalent Unit
Mar 31 2021	BUY Grant, award, or other acquisition	$33,788 $40.66 p/Share	831 Added 8.82%	8,595 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	$1,327 $37.9 p/Share	35 Added 0.45%	7,764 Dividend Equivalent Unit
Dec 31 2020	BUY Grant, award, or other acquisition	$33,773 $34.71 p/Share	973 Added 11.18%	7,729 Common Stock
Nov 12 2020	BUY Grant, award, or other acquisition	$1,310 $29.11 p/Share	45 Added 0.66%	6,756 Dividend Equivalent Unit
Sep 30 2020	BUY Grant, award, or other acquisition	$33,759 $26.17 p/Share	1,290 Added 16.12%	6,711 Common Stock

Also insider at

CVS

CVS HEALTH Corp Healthcare

Director